Advertisement

Topics

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Company Profile

10:23 EDT 21st September 2017 | BioPortfolio


News Articles [3686 Associated News Articles listed on BioPortfolio]

LabCorp completes acquisition of PAML

LabCorp has completed its acquisition of Pathology Associates Medical Laboratories (PAML), which will be integrated into its national network of regional and specialty laboratories.

Concurrent with BMS acquisition, IFM Therapeutics spins off IFM Therapeutics LLC

Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.

Unigene to Present at the 14th Annual BIO CEO & Investor Conference on February 13, 2012

BOONTON, N.J., Feb. 7, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, announce...

Carnegie Mellon's RoboTutor advances to Global Learning XPRIZE semifinals

(Carnegie Mellon University) RoboTutor, educational technology developed at Carnegie Mellon University that teaches children basic math and reading skills, has been named a semifinalist in the $15 mil...

Building a better blood-brain barrier model

Delivering drugs to the brain is no easy task. The blood-brain barrier -a protective sheath of tissue that shields the brain from harmful chemicals and invaders - cannot be penetrated by most therapeu...

Catalysts developed at Carnegie Mellon efficiently and rapidly remove BPA from water

(Carnegie Mellon University) Carnegie Mellon University chemist Terrence J. Collins has developed an approach that quickly and cheaply removes more than 99 percent of bisphenol A (BPA) from water. B...

Researchers develop new approach to build better blood-brain barrier model

Delivering drugs to the brain is no easy task. The blood-brain barrier -a protective sheath of tissue that shields the brain from harmful chemicals and invaders - cannot be penetrated by most therapeu...

Engineers Work to Make 3D Printed Human Heart a Reality

ArticleThe Regenerative Biomaterials and Therapeutics Group at Carnegie Mellon is working on new techniques for 3D bioprinting.Staff Author: 

PubMed Articles [1838 Associated PubMed Articles listed on BioPortfolio]

Current Models of Investor State Dispute Settlement Are Bad for Health: The European Union Could Offer an Alternative Comment on "The Trans-Pacific Partnership: Is It Everything We Feared for Health?"

In this commentary, we endorse concerns about the health impact of the trans-pacific partnership (TPP), paying particular attention to its mechanisms for investor state dispute settlement. We then des...

A Reply to Stiefel et al. "Losing the 'Person' in Personalized Medicine".

An Intrathermocline Eddy and a tropical cyclone in the Bay of Bengal.

The Bay of Bengal, subjected to monsoonal forcing and tropical cyclones, displays a complex field of ocean eddies. On 5 December 2013 a sub-surface vortex or Intrathermocline Eddy (ITE) composed of wa...

Corneal Wound Repair After Rose Bengal and Green Light Crosslinking: Clinical and Histologic Study.

To evaluate corneal wound healing after treatment with a new collagen crosslinking protocol using rose bengal dye and green light (RGX).

Chlamydia trachomatis regulates innate immune barrier integrity and mediates cytokine and antimicrobial responses in human uterine ECC-1 epithelial cells.

Chlamydia trachomatis infection is the most common sexually transmitted bacterial infection worldwide and known to increase the risk for HIV acquisition. Few studies have investigated how infection of...

Clinical Trials [931 Associated Clinical Trials listed on BioPortfolio]

The Acquisition of Blood and Skin Samples From Normal Volunteers to Support Research Activities on Dermatologic Diseases

Background: -This protocol is concerned with the acquisition of blood, skin, or mucosal samples from healthy volunteers or patients with selected skin diseases to support the basic scienc...

Virtual Task in Amyotrophic Lateral Sclerosis

Thirty individuals with ALS (18 men and 12 women, mean age 59 years, range 44-74 years), and 30 healthy controls matched for age and gender, participated. Individuals with ALS and from the...

DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery

To evaluate the safety and effectiveness of DuraGen Plus® Adhesion Barrier Matrix as an adhesion barrier in spinal surgery to reduce the extent of peridural fibrosis formation and radicul...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

VANOS Cream and Skin Barrier Function

The purpose of this study is to determine the effect of short-term therapy using "VANOS Cream," a super-potent topical steroid cream on skin barrier function in patients with atopic dermat...

Companies [2747 Associated Companies listed on BioPortfolio]

Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC

Stiefel Laboratories, Inc.

Stiefel Laboratories is enthusiastically committed to advancing dermatology and skin science around the world. The company's deeply-rooted dedication and drive for innovation along with its sole focus...

Stiefel, a GSK company

Stiefel, a GSK company, is committed to advancing dermatology and skin science around the world in order to help people better achieve healthier skin. Stiefel's dedication to innovation, along with i...

Barrier Therapeutics

BARRIER THERAPEUTICS is a pharmaceutical company focused on the discovery, development and commercialization of pharmaceutical products in the field of dermatology. Our goal is to develop a portfolio ...

Barrier Advisors Inc.

A nationally recognized financial and operational advisory firm with offices in Dallas, Texas and Stamford, Conn., Barrier Advisors provides special situations investment banking,...

More Information about "Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC" on BioPortfolio

We have published hundreds of Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC news stories on BioPortfolio along with dozens of Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Clinical Trials and PubMed Articles about Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Companies in our database. You can also find out about relevant Stiefel Laboratories, Inc., Barrier Therapeutics, Inc., Bengal Acquisition Inc., Mellon Investor Services LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record